BOSTON ONCOLOGY ARABIA and SPIMACO Partner to Localize Advanced Oral Oncology Treatments in Saudi Arabia
In a landmark step towards advancing cancer care in the Middle East, BOSTON ONCOLOGY ARABIA and SPIMACO have signed a Memorandum of Understanding (MoU) to localize the production of advanced oral oncology treatments in the Kingdom. Announced at the CPHI Middle East conference, this partnership reflects a shared commitment to improving patient outcomes, fostering local expertise, and contributing to Saudi Arabia’s Vision 2030 goals for healthcare transformation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250108766769/en/
In a landmark step towards advancing cancer care in the Middle East, BOSTON ONCOLOGY ARABIA and SPIMACO have signed a Memorandum of Understanding (MoU) to localize the production of advanced oral oncology treatments in the Kingdom of Saudi Arabia. (Photo: Business Wire)
Pioneering Pharmaceutical Localization
Focused on the transfer of technology and knowledge, the collaboration will enable the parties to commercialize essential oral oncology medications domestically. The initiative not only improves access to life-saving treatments, but also strengthens the Kingdom’s industrial and healthcare infrastructure.
“This agreement marks a significant milestone toward ensuring that patients in Saudi Arabia and beyond have access to world-class oncology treatments without delay,” said Dr. Abdullah Baaj, CEO of Boston Oncology Arabia. “By localizing production and investing in cutting-edge technologies, we are not just meeting immediate needs—we are modeling a sustainable future for oncology care in the GCC / MENA region.”
SPIMACO CEO Jérôme Cabannes added: "This partnership enhances our ability to provide high-quality oncology treatments and strengthens our commitment to the Kingdom's vision of a self-reliant healthcare system. It reflects our shared dedication to patient care and reinforces our leadership role in the pharmaceutical industry."
Strategic Alignment with Vision 2030
This collaboration reinforces Saudi Arabia’s leadership in regional and global pharmaceutical markets. By establishing local manufacturing capabilities for advanced oral oncology therapies, the partnership aligns with Vision 2030’s goals to reduce dependency on imports, strengthen local industry, and enhance access to innovative treatments for patients across the Kingdom.
Looking Ahead
The partnership will prioritize the commercialization of key oral oncology therapies over the next five years, driving significant benefits including job creation, the development of local expertise and production capacity, and equitable access to critical cancer treatments across Saudi Arabia and the broader MENA region.
This collaboration showcases the potential of bold strategic partnerships to unlock new opportunities to advance oncology care and address critical healthcare needs.
About Boston Oncology Arabia
Headquartered in Riyadh, Boston Oncology Arabia is a leading pharmaceutical company with a mission to impact the lives of one billion patients by 2030. The company is recognized for its innovative approach to conquering market complexity, delivering the full value of its products to the market while achieving outsized and sustainable competitive share. Focused on the licensing, local development, and manufacturing of world-class medicines, Boston Oncology Arabia’s end-to-end supply chain ensures transformative access to essential therapeutics—reaching hospital systems swiftly, reliably and affordably.
Learn more at https://bostononcology.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250108766769/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lemonway Unveils Online Onboarding Solution for Marketplaces, Powered by Entrust Identity Verification Solution9.1.2025 17:50:00 CET | Press release
Lemonway, a leading European payment institution, proudly announces the launch of Online Onboarding, an innovative solution designed to streamline and enhance the merchant onboarding process for marketplaces. Available now, Online Onboarding eliminates the need for marketplaces to manage new customer onboarding themselves, allowing them to focus on strategy and business growth while staying competitive in the eyes of their partners. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250109672706/en/ This turnkey solution offers a seamless, automated onboarding process, combining Lemonway’s expertise in payments with Entrust ETSI-certified identity verification with Qualified Electronic Signature (QES), powered by Entrust’s Onfido Identity Verification solution. As a result, marketplaces rely on Lemonway to secure the complex, compliance-driven onboarding journey, ensuring a secure and efficient experience for their merchants. Ke
LambdaTest Transforms Visual Testing with the Introduction of New Features in the SmartUI Visual AI Engine for Flawless Digital Experiences9.1.2025 17:00:00 CET | Press release
LambdaTest announces enhancements in the SmartUI Visual AI Engine, which uses advanced AI to improve visual testing accuracy and accelerate flawless digital experiences. LambdaTest, a leading cloud-based unified testing platform, has enhanced its SmartUI Visual AI Engine to transform visual testing further and improve digital experiences. With these enhancements, SmartUI empowers developers and testers to effortlessly eliminate tricky visual bugs, reduce noise in test results, and ensure websites and apps appear flawless to users. The Visual AI Engine now employs advanced, homegrown algorithms to reduce visual noise, address layout shifts, and pinpoint significant changes on web pages, ensuring cleaner and more accurate testing results. SmartUI also introduces innovative features such as Page Shift Detection, anti-aliasing noise reduction, and advanced text stabilization powered by Optical Character Recognition (OCR). These enhancements drastically minimize false positives and improve
Onera Health Appoints Maria Sainz as Chair of the Board9.1.2025 17:00:00 CET | Press release
Onera Health, a leader in transforming sleep diagnostics and monitoring, is excited to announce the appointment of Maria Sainz as the new Chair of the Board of Directors. Sainz's experience in the healthcare technology sector and her proven track record in strategic leadership will be instrumental as Onera Health pursues its mission to enhance patient care by increasing access to cost-effective home polysomnography (PSG) through its innovative and unparalleled Onera PSG-as-a-Service solution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250109336176/en/ Maria Sainz is the newly appointed Chair of the Board of Directors at Onera Health. (Photo: Business Wire) Maria Sainz has over 30 years of experience in the medical device industry, having held leadership positions at several prestigious healthcare organizations, both private and publicly traded. Her extensive background includes senior roles in strategic planning, operati
MarginEdge Selects BlueSnap as North American Subscription Payments Partner9.1.2025 15:00:00 CET | Press release
Restaurant management software company to leverage BlueSnap’s innovative platform to consolidate subscription payment processing and enable seamless cross-border transactions between U.S. and Canada BlueSnap, a global payment orchestration platform for leading B2B and B2C businesses, today announced its selection by MarginEdge, a provider of restaurant management solutions, as its North American client billing partner. MarginEdge helps restaurant owners and managers get out of the back office and back onto the restaurant floor by automating their operations. Its comprehensive platform of restaurant management solutions includes inventory management, access to real-time food costs, and integrated payments for operators to easily pay their bills. MarginEdge selected BlueSnap’s next-generation solution to streamline the collection of client billing across North America – an important infrastructure update as the company continues to grow its customer base outside of the US. “BlueSnap quic
EV Group successfully finalises an investment in Cornelius Group plc through a minority equity stake.9.1.2025 14:33:00 CET | Press release
EV Group, a leading specialty chemicals and food ingredients distributor and manufacturer, and Cornelius Group (Cornelius), an international manufacturer and distributor of specialty additives and ingredients to the life sciences and performance chemicals markets, announce today that they have reached binding agreements for the acquisition by EV of a minority stake in Cornelius. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250109291745/en/ Photographed (Left to Right): Darren Spiby, Joint CEO, Cornelius Group plc; Phillip Gibbons, Joint CEO, Cornelius Group plc; Dr Neville Prior, Group Chairman, Cornelius Group plc; Ludovico Balbo di Vinadio, Shareholder and Deputy Chairman, EV Group; Cristina Colombo, Chief Financial Officer, EV Group; Gabriele Bonomi, Chief Executive Officer, EV Group. (Photo: Business Wire) Under the terms of the transaction, EV Group will increase its stake in Cornelius through additional equity acquis
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom